David P Perry's Net Worth

$2.11 Million

Estimate Recalculated Sep 9, 2024 12:26AM EST

Who is David P Perry

David P Perry has an estimated net worth of $2.11 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, Evelo Biosciences, Inc., Better Therapeutics, Inc., and NEXPRISE INC.

SEC CIK

David P Perry's CIK is 0001105941

Past Insider Trading and Trends

2021 was David P Perry's most active year for acquiring shares with 10 total transactions. David P Perry's most active month to acquire stocks was the month of April. 2014 was David P Perry's most active year for disposing of shares, totalling 8 transactions. David P Perry's most active month to dispose stocks was the month of November. 2024 saw David P Perry paying a total of $409,999.86 for 2,311,348 shares, this is the most they've acquired in one year. In 2014 David P Perry cashed out on 145,000 shares for a total of $2,630,510.25, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anacor Pharmaceuticals Inc

President and CEO
Updated Mar 06, 2014
Form 4
-15.25%
-65.00K
$20.22
-$1.31M
Mar 06, 2014
361.31K
Sale
ScheduledMar 04 - Mar 05
Form 4
165.00K
Feb 10, 2014
165.00K
Grant
Feb 07
Form 4
-3.40%
-15.00K
$17.00
-$255.01K
Feb 05, 2014
426.31K
Sale
ScheduledFeb 04 - Feb 05
Form 4
-12.84%
-65.00K
$16.32
-$1.06M
Jan 09, 2014
441.31K
Sale
ScheduledJan 08 - Jan 09
Form 4
-7.38%
-40.33K
$8.42
-$483.30K
Dec 09, 2013
506.31K
Sale
ScheduledDec 05 - Dec 09
Form 4
185.00K
Apr 16, 2013
185.00K
Grant
Apr 12
Form 4
125.00K
Mar 14, 2012
125.00K
Grant
Mar 13
Form 4
185.00K
Apr 04, 2011
185.00K
Grant
Mar 31
Form 3
Nov 23, 2010
261.15K
Showing 9 results

Evelo Biosciences, Inc.

Investor
Updated Jun 11, 2021
Form 4
17.50K
Jun 11, 2021
17.50K
Grant
Jun 08 - Jun 09
Form 4
15.69K
Jun 18, 2020
15.69K
Grant
Jun 17
Form 4
15.69K
Jun 13, 2019
15.69K
Grant
Jun 12
Form 3
May 08, 2018
Showing 4 results

Better Therapeutics, Inc.

Executive Chairman
Updated Feb 13, 2024
Form 4
53.27%
839.89K
$0.19
$160.00K
Feb 13, 2024
19.40M
Grant
Feb 09
Form 4
1,397.58%
1.47M
$0.17
$250.00K
Jan 10, 2024
18.56M
Grant
Jan 09
Form 4
3.69%
3.75K
Dec 20, 2023
17.09M
Grant
Dec 18
Form 4
10.45%
1.23M
$0.73
$900.00K
Jul 31, 2023
17.08M
Purchase
Jul 27
Form 4
15.00K
Jun 09, 2023
15.00K
Grant
Jun 07
Form 4
47.49%
4.97M
$0.83
$4.10M
Apr 12, 2023
15.85M
Purchase
Apr 10
Form 4
97.02%
50.00K
$2.05
$102.60K
Sep 19, 2022
10.88M
Purchase
Sep 15 - Sep 16
Form 4
15.00K
Jun 10, 2022
15.00K
Grant
Jun 09
Form 4
34.68%
10.86M
$9.97
$3.51M
Nov 01, 2021
42.16M
Purchase
Apr 30 - Oct 28
Form 3
Nov 01, 2021
10.83M
Showing 10 results

NEXPRISE INC

Investor
Updated Apr 26, 2004
Form 4
1.11%
1.67K
Apr 26, 2004
151.93K
Grant
Apr 22
Showing 1 results